Health Canada drug identification number

DIN 02441071 — TEVA-TOPOTECAN 4 MG

TEVA-TOPOTECAN is a powder for solution of Topotecan marketed by TEVA CANADA LIMITED. The full Topotecan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02441071
Brand name
TEVA-TOPOTECAN
Active ingredient
Topotecan
Strength
4 MG
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
TEVA CANADA LIMITED
Health Canada status
MARKETED
Drug class
Topoisomerase I inhibitor (antineoplastic agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Topotecan products

DINBrandStrengthFormManufacturerStatus
02379422 TOPOTECAN HYDROCHLORIDE FOR INJECTION 1 MG SOLUTION PFIZER CANADA ULC MARKETED
02396378 TOPOTECAN HYDROCHLORIDE FOR INJECTION 1 MG SOLUTION ACCORD HEALTHCARE INC MARKETED
02390981 TOPOTECAN INJECTION 1 MG SOLUTION SANDOZ CANADA INCORPORATED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.